Drugs that contain Ivermectin
1. Sklice patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6103248 | ARBOR PHARMS LLC | Topical preparation and therapy for head lice |
May, 2018
(5 years ago) | |
| US8927595 | ARBOR PHARMS LLC | Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice |
Oct, 2027
(3 years from now) | |
| US8791153 | ARBOR PHARMS LLC | Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice |
Oct, 2027
(3 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Feb 07, 2015 |
Market Authorisation Date: 07 February, 2012
Treatment: For head lice infestations
Dosage: LOTION;TOPICAL
How can I launch a generic of SKLICE before it's drug patent expiration?
More Information on Dosage
SKLICE family patents
2. Soolantra patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5952372 | GALDERMA LABS LP | Method for treating rosacea using oral or topical ivermectin |
Sep, 2018
(5 years ago) | |
| US6133310 | GALDERMA LABS LP | Method of treatment of rosacea |
Apr, 2019
(4 years ago) | |
| US8815816 | GALDERMA LABS LP | Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
Apr, 2024
(3 days from now) | |
| US8093219 | GALDERMA LABS LP | Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
Apr, 2024
(3 days from now) | |
| US8080530 | GALDERMA LABS LP | Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
Apr, 2024
(3 days from now) | |
| US8415311 | GALDERMA LABS LP | Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
Apr, 2024
(3 days from now) | |
| US11033565 | GALDERMA LABS LP | Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
Apr, 2024
(3 days from now) | |
| US8470788 | GALDERMA LABS LP | Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
Apr, 2024
(3 days from now) | |
| US7550440 | GALDERMA LABS LP | Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
Apr, 2024
(3 days from now) | |
| US9089587 | GALDERMA LABS LP | Treatment of papulopustular rosacea with ivermectin |
Mar, 2034
(9 years from now) | |
| US10206939 | GALDERMA LABS LP | Treatment of papulopustular rosacea with ivermectin |
Mar, 2034
(9 years from now) | |
| US9782425 | GALDERMA LABS LP | Treatment of papulopustular rosacea with ivermectin |
Mar, 2034
(9 years from now) | |
| US9233117 | GALDERMA LABS LP | Treatment of inflammatory lesions of rosacea with ivermectin |
Mar, 2034
(9 years from now) | |
| US9233118 | GALDERMA LABS LP | Treatment of papulopustular rosacea with ivermectin |
Mar, 2034
(9 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Dec 19, 2017 |
Market Authorisation Date: 19 December, 2014
Treatment: Treatment of inflammatory lesions of rosacea.
Dosage: CREAM;TOPICAL
How can I launch a generic of SOOLANTRA before it's drug patent expiration?
More Information on Dosage
SOOLANTRA family patents